PlainRecalls
FDA Devices Moderate Class II Terminated

FastPack Free T4 Immunoassay FastPack Vitamin D Immunoassay Chemilunescence assay for the determination of Vitamin D The FastPack Vitamin D Immunoassay is intended for the quantitative determination of FastPack Total PSA Immunoassay Chemilunescence assay for the determination of Total PSA FastPack Total PSA Immunoassay is a paramagnetic particle immunoassay for the in vitro quantitative determination of prostate-specific antigen (PSA) in human serum and plasma as an aid in the management

Reported: December 25, 2013 Initiated: November 8, 2013 #Z-0550-2014

Product Description

FastPack Free T4 Immunoassay FastPack Vitamin D Immunoassay Chemilunescence assay for the determination of Vitamin D The FastPack Vitamin D Immunoassay is intended for the quantitative determination of FastPack Total PSA Immunoassay Chemilunescence assay for the determination of Total PSA FastPack Total PSA Immunoassay is a paramagnetic particle immunoassay for the in vitro quantitative determination of prostate-specific antigen (PSA) in human serum and plasma as an aid in the management of patients with prostate cancer.

Reason for Recall

Qualigen initiated this recall because the FastPack kit may cause lower than expected results due to a manufacturing defect.

Details

Recalling Firm
Qualigen Inc
Units Affected
6
Distribution
US Distribution to states of: AL, CA, KS, KY, IN, MA, NC, NY, NV, OK, SC, TN, TX, UT, VA, and WA.
Location
Carlsbad, CA

Frequently Asked Questions

What product was recalled?
FastPack Free T4 Immunoassay FastPack Vitamin D Immunoassay Chemilunescence assay for the determination of Vitamin D The FastPack Vitamin D Immunoassay is intended for the quantitative determination of FastPack Total PSA Immunoassay Chemilunescence assay for the determination of Total PSA FastPack Total PSA Immunoassay is a paramagnetic particle immunoassay for the in vitro quantitative determination of prostate-specific antigen (PSA) in human serum and plasma as an aid in the management of patients with prostate cancer.. Recalled by Qualigen Inc. Units affected: 6.
Why was this product recalled?
Qualigen initiated this recall because the FastPack kit may cause lower than expected results due to a manufacturing defect.
Which agency issued this recall?
This recall was issued by the FDA Devices on December 25, 2013. Severity: Moderate. Recall number: Z-0550-2014.